Caribbean Air Force

Barbados Targets 2027 Launch of Robotic Cancer Surgery in Public Healthcare

The Barbados government is positioning itself to democratise access to advanced cancer treatment by introducing robotic surgery in the public healthcare system within the next year. According to Barbados Today, Health Minister Senator Lisa Cummins made the announcement at the Barbados Cancer Society’s annual general meeting, signalling a commitment to closing the disparity between what private and public patients can access.

Currently, robotic surgery for prostate and gynaecological cancers is available only through private healthcare in Barbados. The government has begun engagement with Northwell Health, a New York-based nonprofit healthcare network with over 105,000 employees, to establish the infrastructure and expertise needed locally. Healthcare personnel will travel to Northwell facilities for intensive ten-day training rotations, while specialists from the American health system will also visit Barbados to support the transition.

Beyond surgical innovation, the ministry is pursuing a broader cancer care strategy. Cummins announced plans to introduce genomic testing during the next financial year, enabling early identification of disease predisposition in patients of all ages, including newborns. The government has also negotiated with the Pan American Health Organisation to merge its Strategic and Revolving Funds, potentially expanding access to high-cost cancer medications currently unavailable in Barbados starting in April.

The minister acknowledged that early detection means little without timely treatment access. She highlighted ongoing efforts to address surgical backlogs at the Queen Elizabeth Hospital, where department heads are reviewing cases to establish clearer prioritisation. Additionally, Northwell has offered to share blood-testing technology used in the United States to detect common cancers early.

The Cancer Society itself is advancing screening innovation. According to the report, immediate past president Professor David Rosin noted that the society’s genomic and DNA/RNA screening trials for prostate and colon cancer represent world firsts, with a breast cancer trial in development. Rosin acknowledged that Barbados lags leading nations by approximately 25 years in common cancer treatment, though he expressed confidence the country would narrow that gap.

At the meeting, members elected Sonya Alleyne as the society’s new president, alongside a slate of officers and directors tasked with supporting expanded screening and patient care initiatives.

The Barbados Cancer Society has established itself as a research and advocacy leader in the Caribbean, developing screening protocols adopted internationally. The organisation’s clinical trials using advanced genomic testing represent cutting-edge work in cancer detection, though membership has declined to approximately one-third of its level 17 years ago.

This development signals a shift in Caribbean healthcare equity, where advanced cancer treatment has typically been accessible only to those with private insurance or the means to travel abroad. Barbados’s move to introduce robotic surgery and genomic testing in the public system could influence regional health policy and set a precedent for other Caribbean nations seeking to modernise cancer care infrastructure.

Sources and attribution

Share This News Update

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top